⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Beispiellose Ergebnisse der Phase III Studie MajesTEC-3 sprechen für TECVAYLI®▼ (teclistamab) plus DARZALEX® (daratumumab) in subkutaner Formulierung als potenzieller Behandlungsstandard bereits in der Zweitlinienbehandlung für Patienten mit
globenewswire.com
JNJ
Disease-Modifying Therapies Market to Surpass USD 112.6 Billion by 2033 as Biologic Innovation Redefines Long-Term Disease Control
prnewswire.com
JNJ
ABBV
AZN
GSK
AMGN
RIS Rx Appoints Stuart McGuigan to Board of Directors
businesswire.com
FMS
JNJ
CVS
Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies
globenewswire.com
ABBV
BMY
GILD
AMGN
AZN
LLY
BIIB
REGN
VRTX
XBI
IBB
CRSP
EDIT
NTLA
ABCL
NVS
MRK
PFE
JNJ
GSK
SNY
BTAI
INSM
Insightec Announces Spin-Out of Lotus Neuro to Advance Focused Ultrasound Brain Therapies USA - English Israel - English
prnewswire.com
JNJ
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
globenewswire.com
CAH
JNJ
PFE
IQV
IOBT
BaseLaunch Announces the Addition of Takeda as New Pharmaceutical Partner to its Biotech Venture Incubator
prnewswire.com
JNJ
ABBV
Cradle AI-powered protein engineering platform serving six of top 25 pharma leaders
prnewswire.com
JNJ
ABBV
GOOG
META
UBER
GNPX
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
businesswire.com
JNJ
Alger Russell Innovation Index Updates for Fourth Quarter 2025
prnewswire.com
CCC
DOX
DUOL
FFIV
GDDY
GNTX
ZBRA
CORT
EA
GILD
JNJ
QRVO
UTHR
VRTX